Results 161 to 170 of about 3,014 (182)

Erdafitinib/pembrolizumab

Reactions Weekly, 2023
openaire   +1 more source

Clinical Evidence and Selecting Patients for Treatment With Erdafitinib in Advanced Urothelial Carcinoma

OncoTargets and Therapy, 2022
Neeraj Agarwal, Umang Swami, Nicolas Sayegh   +2 more
exaly  

Erdafitinib for Locally Advanced or Metastatic Urothelial Carcinoma

American Journal of Health-System Pharmacy, 2022
Arlene O Siefker-Radtke, Yohann Loriot
exaly  

Erdafitinib for the Treatment of Metastatic Bladder Cancer

Expert Review of Clinical Pharmacology, 2020
Joaquim Bellmunt
exaly  

Erdafitinib/osimertinib

Reactions Weekly, 2020
openaire   +1 more source

LC-MS/MS Determination of Erdafitinib in Human Plasma After SPE: Investigation of the Method Greenness

Microchemical Journal, 2020
Fathalla Belal, Tarek Elawady, Alaa Khedr   +2 more
exaly  

HPLC-UV Determination of Erdafitinib in Mouse Plasma and Its Application to Pharmacokinetic Studies

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2021
Fathalla Belal, Tarek Elawady, Alaa Khedr   +2 more
exaly  

Erdafitinib: A Novel Therapy for FGFR-Mutated Urothelial Cancer

American Journal of Health-System Pharmacy, 2020
Zin W. Myint
exaly  

Erdafitinib/infigratinib/zoligratinib

Reactions Weekly, 2023
openaire   +1 more source

Erdafitinib in Zweit-/Drittlinientherapie

Uro-News, 2022
openaire   +1 more source